These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
To get nformation about pending patent expiries in the pharmaceutical market
— Sales, Sweden
To learn about drugs that will be coming off patent and to offer an ANDA in their master drug file
— Global market development manager, healthcare packaging provider, USA
To conduct drug patent landscape analysis
— Pharmaceutical R&D, China
To get Information about drug patent expiry for drugs approved in Germany and UK since 1990
— Economist, Germany
To identify APIs going off-patent in the next few years
— API manufacturer, India
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
